Jasper Ridge Partners’s Immunomedics Inc IMMU Stock Holding History

Jasper Ridge Partners’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,924	Closed	-$929K	–	117
2020 Q3	$929K	Hold	10,924	–	–	0.05%	79
2020 Q2	$387K	Hold	10,924	–	–	0.03%	88
2020 Q1	$147K	Hold	10,924	–	–	0.01%	96
2019 Q4	$231K	Hold	10,924	–	–	0.02%	94
2019 Q3	$145K	Hold	10,924	–	–	0.01%	92
2019 Q2	$152K	Hold	10,924	–	–	0.01%	94
2019 Q1	$210K	Hold	10,924	–	–	0.01%	84
2018 Q4	$156K	Hold	10,924	–	–	0.01%	71
2018 Q3	$228K	Hold	10,924	–	–	0.01%	71
2018 Q2	$259K	Buy	+10,924	New	+$220K	0.02%	64

Jasper Ridge Partners's IMMU Position: Q4 2020 in Review

Jasper Ridge Partners sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 10,924 shares — an estimated $929K sold.

Jasper Ridge Partners first reported a position in IMMU in Q2 2018 and held it in 10 quarters. The position peaked at $929K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Jasper Ridge Partners reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Jasper Ridge Partners sold 10,924 Immunomedics Inc shares in Q4 2020, an estimated $929K.
Jasper Ridge Partners first reported a position in Immunomedics Inc in Q2 2018 and held it in 10 quarters.
Jasper Ridge Partners's Immunomedics Inc position peaked at $929K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Jasper Ridge Partners's 13F filing for Q4 2020, filed 12 Feb 2021.